PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Fertil Steril. Author manuscript; available in PMC 2014 June 1.
Published in final edited form as:
PMCID: PMC3672332
NIHMSID: NIHMS444441

Detection and quantification of maternal-effect gene transcripts in mouse second polar bodies: potential markers of embryo development competence

Ze-Xu Jiao, M.D., Ph.D.+ and Teresa K Woodruff, Ph.D.

Abstract

Objective

To test the hypothesis that quantification of mRNAs originating the second polar body (PB2) provides a non-invasive tool for assessing embryo quality.

Design

Prospective study

Setting

Hospital-based academic research laboratory

Animals

CD1 female mice

Intervention(s)

MII oocytes obtained from 7- to 8-week-old mice after pregnant mare’s serum gonadotrophin (PMSG) and human chorionic gonadotrophin (hCG) priming. After in vitro fertilization, the PB2 was biopsied from zygotes followed by reverse transcription. Real-time PCR was performed to quantify gene expression levels in single PB2. The sibling zygotes were continuously cultured to blastocyst stage.

Main Outcome Measure(s)

Embryo developmental competence and six maternal-effect gene (Dnmt1, Mater, Nobox, Npm2, Tcl1 and Zar1) transcripts in the PB2

Results

PB2 mRNA was detected in all candidate genes. Transcripts that were present in greater abundance in the zygote were more likely to be detected in qPCR replicates from single PB2. 4 candidate genes (Dnmt1, Nobox, Npm2 and Tcl1) expression levels in PB2 between two groups (2-cell embryo vs. blastocyts) approached statistical significance.

Conclusion

PB2 may contain a representative transcript profile to that of the zygote after fertilization. Differences in gene expression in PB2 may be potential biomarkers of embryo quality.

Keywords: infertility, meiosis, maternal-effect genes, embryo quality

Despite remarkable progress in both the clinical and embryological aspects of assisted reproductive technologies (ART), the live birth rate is still disappointingly low. The ratio of oocytes harvested to live-born babies is approximately 25:1 for young women (1). 85% of embryos produced in vitro and transferred in the uterus fail to develop into an infant (2). The utilization of the most competent embryo during in vitro fertilization (IVF) is crucial to ensure a successful pregnancy. Currently, the morphological criteria and the standard cytogenetic methods used to select and classify embryo are not sufficient for predicting the IVF outcomes. The lack of reliable predictors of oocyte/embryo developmental competence hampers the effectiveness of assisted reproductive technology (ART) (3, 4). Thus, there is an urgent need to identify more objective, predictive, and non-invasive markers to choose the embryos with the highest implantation potential to be prioritized for transfer to the uterus (5).

Development of a mammalian embryo starts with fertilization, the fusion of sperm and egg and formation of a totipotent zygote. After fertilization, the mouse sperm is incorporated into the cytoplasm of the egg and provides DNA for the male pronucleus, which is essential for egg activation. However, earlier studies have demonstrated that the sperm play no major role in cleavage-stage embryogenesis, the maternal genome controls virtually all aspects of early animal development (6, 7). The most conclusive evidence that stored maternal-effect determinants are required for embryonic developmental competence has come from loss-of-function studies in the mouse. Loss of maternal Mater(8), Zar1 (9) and Npm2 (10) transcripts causes the arrest of development at embryonic genome activation stage. Embryos derived from Tcl1-mull females have delayed cleavage-stage progression with decreased fecundity (11). Nobox plays an important role of regulation embryonic genome activation, pluripotency gene expression, and blastocyst cell allocation (12). As markers of embryo quality, assessment of maternal-effect mRNA expression levels may provide a way to more objectively assess and predict the developmental competence of embryo; such an approach may ultimately aid in improving implantation rate in IVF (13). However, due to the drawback that assessing maternal-gene expression profile has the risk of damaging the oocyte during sampling, it is still not known whether maternal-effect molecular markers that could be used to predict the developmental competence of embryo.

A polar body (PB) is the byproduct of an oocyte meiotic division. The first PB (PB1) is extruded as the oocyte matures and resumes meiosis I prior to ovulation. The second PB (PB2) is extruded following fertilization and resumption of meiosis II. There is no clear evidence of the fate of the PB in any mammal including the mouse, which is the commonly used research model. However, the PB is generally considered as waste material, and therefore not essential to embryo development. In recent years the PB has gained prominence as they have been used as a DNA source representative of the oocyte for genetic testing (14). PB1 mRNA also is being considered as a proxy for the oocyte in tests for oocyte competence and embryonic viability (1517). The ability to quantify mRNA in a single PB—opens up the possibility that we can detect and compare individual differences in gene expression in the PB without harming the oocyte (18).

The PB2 is produced by asymmetric cytokinesis ~2h after sperm-egg fusion, ~10h before major zygotic transcription in mouse (19). PB2 contains about 4.5% of the zygote volume and one maternal chromosome set and a hemi-spindle. PB2 can be present in the perivitelline space of the developing embryo for several days and usually completely decays before the embryo reaches the blastocyst stage (20, 21). Isolation of the PB2 after fertilization can be regarded as a non-invasive proxy for cytoplasmic sampling of the oocyte from which the zygote was formed (22).

In this study, we have set out to examine the expression of six maternal effect genes in the PB2. The candidate genes were chosen based on their important roles in early embryo development in mouse (Table 1). We first compared transcript abundance between PBs and their sibling zygotes, and then we asked whether that relative abundance of mRNA transcripts in PB2 is a marker of embryo developmental competence.

Table 1
Maternal-effect genes selected for testing in individual PBs and sibling zygotes

Materials and Methods

Animals

We obtained Institutional Review Board (IRB) permission to perform the animal experiments in this study. CD1 mice were housed and bred in a controlled barrier facility within Northwestern University’s Center for Comparative Medicine (Chicago, IL) in a temperature- and light-controlled environment (12L:12D) and were provided with food and water ad libitum. All mice were maintained in accordance with the policies of Northwestern University’s Animal Care and Use Committee and National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals.

Collection and culture of MII oocytes

MII oocytes were collected from 7- to 8-week-old female mice after superovulation was induced by intraperitoneal injection of a single dose (5 IU) of pregnant mare’s serum gonadotropin (PMSG; Calbiochem, La Jolla, CA) followed by the same dose of human chorionic gonadotropin (hCG) (Intervet, Canada) 46–48 hours later. Cumulus oophorous complexes (COC) were recovered from ampullae into Leibovitz L15 medium containing 1% fetal bovine serum (FBS) 14 hours after hCG administration. Oocytes were dissociated from the surrounding cumulus cells using 0.3 mg/ml hyaluronidase (Sigma, St. Louis, MO) in order to identify MII oocytes. After the removal of cumulus-corona cells, only those MII oocytes that had extruded a PB were collected. All oocyte and embryo culture was in humidified CO2 (5% (v/v) in air) at 37°C.

Collection of Zygotes Following In vitro Fertilization (IVF)

For in vitro fertilization of oocytes, motile sperm were prepared from a sperm suspension collected from the cauda epididymis of proven CD-1 male breeder mice. A total of ~30 MII oocytes were placed in 50 μl of IVF medium microdrops containing 1x106 sperm/ml and incubated under mineral oil for 4 h. Zygotes were chosen as those having a clear pronuclei, but do not have an extant PB1 to assist with identification of PB2 extrusion and reduce contamination with mRNA from earlier stages. Following incubation, each zygote was then washed 3 times in fresh KSOM to remove all bound sperm.

Polar Body Biopsy and Blastocyst Culture

For laser microdissection, a zygote was aspirated with a holding capillary tube. After positioning, a single hole in the ZP was drilled with the XYClone laser system (Hamilton Thorne Biosciences). The PB2 was gently aspirated into a 19 μm biopsy pipette and put separately from the zygote. Subsequently single PBs were aspirated into a fine glass needle and transferred to the bottom of 0.5-ml thin-wall Eppendorf tubes containing 1.5 μl lysis buffer (0.8% Igepal, 1U RNAsin/μl, 5nM DTT) (23). The Sibling zygotes were either transferred to an identical lysis solution or washed in KSOM and then transferred into a 15-μl drop fresh KSOM cultured to the blastocyst stage individually. Culture media was changed every 48 hours. The lysed specimens were flash-frozen in liquid nitrogen and stored at −80°C in preparation for cDNA synthesis.

Reverse Transcription (RT)

Total mRNA within lysed single PBs and their sibling zygotes was reverse transcribed using the AccuScript High Fidelity 1st Strand cDNA Synthesis Kit (Stratagene, La Jolla, CA) without prior RNA purification from the lysate. To normalize for variations in mRNA content among individual PB and oocyte lysates, 106 copies of a plasmid-derived RNA transcript (pw109, Perkin-Elmer GeneAmp RNA PCR kit) were added to each sample prior to RT as an exogenous control for RNA recovery and efficiency of reverse transcription (24). Samples with less pw109 RNA than controls were excluded from further study. RT was performed by adding the following to each sample: 7.7 μl nuclease-free water, 2 μl 10× RT buffer, 0.8 μl dNTP (2.5 mM of each dNTP), and 3 μl random primers (0.1 μg/μl). Reactions were incubated at 65°C for 5 minutes then cooled to room temperature (approximately 5 minutes). Next, 2 μl of 100 mM dithiothreitol, 0.5 μl RNAse inhibitor (40 U/μl), and 1 μl reverse transcriptase (50 U/μl) per sample were added; the reactions were incubated at 42°C for 60 minutes and then terminated by heating to 70°C for 15 minutes.

Real-time Quantitative PCR (qPCR)

Gene expression levels in PB2 and sibling zygotes were determined for 6 candidate genes (Table 1). Real-time qPCR was performed using the ABI PRISM 7900 sequence detection system (Applied Biosystems, Forest City, CA). For each reaction, 0.5 μl cDNA, 0.5 μl primers, 5 μl TaqMan Universal PCR Master Mix (Applied Biosystems), and 4 μl nuclease-free water were added to a final volume of 10 μl. PCR cycling conditions were 95°C for 10 minutes, followed by 50 amplification cycles of 95°C for 15 seconds and 60°C for 1 minute. To maximize accuracy, each sample was run 3 times with a negative control of reaction mixture with no cDNA added.

Statistical Analysis

Statistical comparisons for qRT-PCR results were analyzed using t-test and one-way ANOVA. Linear regression analysis was performed to test if mean oocyte Ct value could predict detection of mRNA in sibling polar bodies. Stepwise multiple regression analysis was constructed to determine the predictive value for embryo development. The calculation of gene expression was as fold change (2−ΔΔCt) and relative mRNA level [ΔCt = Ct(Target) - Ct(18s). The lower ΔCt means the higher mRNA expression lever in this study]. Data were reported as mean ± SD. P < 0.05 was considered statistically significant. All statistical calculations were performed using the software GraphPad Prism version 4.0.

RESULTS

Analysis of Relative mRNA Expression Levels in Zygote and PB2

We first investigated the presence of mRNA to test the feasibility of our quantification methods. Candidate maternal-effect genes were selected for their importance in murine post-fertilization development (Table 1). The expression of 6 maternal-effect transcripts was analyzed in individual PB2 and sibling zygote (n=10 in each group) using real-time qPCR. mRNA was detected and quantified for all of the 6 candidate genes in both zygote and single PB2. None of the qPCR reactions amplified product from the negative controls. About 99.4% of replicates from single zygote samples yielded an exponential amplification curve for its candidate gene. In single PB2 samples, transcripts of all the 6 selected candidate genes were detected by real-time qPCR. However, the amplification rate was lower in the PB compared with its sibling zygote (78.9% vs. 99.4%). Genes that were more reliably detected in polar bodies had consistently more abundant transcripts (lower mean oocyte and polar body Ct values; Table II).

Relative Abundance of Selected mRNA Transcripts in PB2 vs. Sibling zygote

The relative levels of all 6 maternal-effect mRNA transcripts were lower in individual PB2 compared with their sibling zygote. We set the normalized level of each transcript in the sibling zygote at 1, and then determined the fold change in transcript abundance in PB2. The change in transcript levels was between 0.52-fold (Tcl1) and 0.93-fold (Nobox) (Fig. 1).

FIGURE 1
The relative abundance of each of the 6 maternal-effect genes in PB2 compared with their sibling zygote. If the normalized mRNA level of each transcript in the sibling zygotes is set at 1, the abundance of the transcripts in PB2 was consistently lower ...

Genes in PB2 Reflect the Embryo Developmental Competence

After 5 days culture, we categorized embryos into four groups according to morphological changes during preimplantation development (Each group was evaluated in a minimum of 10 embryos): 2-cell embryo (maternal-zygotic transition, n=11), cleavage embryo (increase in cell number to 4–8 cells, n=12), morulae (polarization and cellular flattening, n=10), and blastocyst (formation of blastocoels, n=12).

In the first analysis, the relative mRNA transcripts per PB2 resulting in different developmental stage embryos were compared. We found Dnmt1, Nobox and Npm2 expression were significantly higher in PB2 that yielded blastocysts vs. 2-cell embyro. These differences were also found in PB2 Npm2 expression yielding cleavage embryo vs. 2-cell embryo. Moreover, Tcl1 was significantly up-regulated in the PB2 of sibling zygote that produced embryos with high developmental potential (Fig. 2, P < 0.05).

FIGURE 2
PB2 gene expression in relate to the different stages of preimplantation embryo development. Dnmt1, Nobox and Npm2 expression were significantly higher in PB2 that yielded blastocysts vs. 2-cell embyro. These differences were also found in PB2 Npm2 expression ...

After statistically significant correlations of gene expression to embryo quality were found, a stepwise multiple regression analysis was performed to characterize further the candidate genes as predictors of embryo developmental competence. Results showed that there was a statistically significant relationship at the 99% confidence level between embryo quality and Dnmt1 expression and at the 95% confidence level for Tcl1 expression. The predictive model was Y= 9.726 - 0.248XDnmt1 - 0.351XTcl1 (R2=0.61).

DISCUSSION

This is the first report, to our knowledge, documenting the quantification of maternal-effect transcripts in mouse PB2, and providing an insight into the relationship between gene expression in PB2 and embryo quality.

We first analyzed the transcripts expressed in individual zygotes alongside their polar body siblings, and show that after the PB2 is extruded, the transcripts of both single zygotes and single polar bodes can be assessed quantitatively. Global measurements have indicated that during oogenesis, mRNA is actively transcribed and accumulated in growing oocytes. Fully-grown oocytes contain about 20 to 45% of all mouse genes (25). Oocyte become transcriptionally quiescent during meiotic maturation in the ~12 hours prior to ovulation and a large fraction of the maternally supplied mRNAs is degraded by the two-cell stage (26, 27). Although the mechanisms responsible for these RNAs degradation are incompletely understood, this degradation must have some selectivity (28). Gene expression profiling experiments have provided evidence that some maternal transcripts are degraded rapidly after fertilization if they encode proteins that play a role in specific events during meiosis and are detrimental for development after fertilization; others show a later decrease that coincides with the major onset of transcription at the two-cell stage if the maternal factors are required to bridge the interregnum between the maternal and embryonic control of development. However, how mouse oocytes store and degrade maternal mRNAs in not well understood (2831). Our results also show the wide variations in the probability of detection of the 6 maternal-effect genes in PB2 and transcripts that were present in greater abundance in the zygote were more likely to be detected in qPCR replicates from single polar bodies. The understanding of which factors determine maternal-effect genes degeneration in individual zygote and species-specific differences in degeneration rates could be used to find links between specific molecular features and the embryo’s acquisition of development competence.

When we compared the transcripts between PB2 and the sibling zygote, the results showed that the abundance of transcripts for the 6 genes would be lower but varied in PBs compared to their sibling oocytes. VerMilyea et al. compared transcriptome profiles of paired single cell and sub-cellular structures obtained microsurgically from mouse oocytes to totipotent embryos and demonstrated there is transcriptome asymmetric within mouse zygotes but not between early embryonic sister blastomeres (22). It is well documented that the targeted localization of cytoplasmic mRNA is a key mechanism by which asymmetric patterning is achieved in metazoan oocytes and early totipotent embryos that establish stem cell lineages (32). These works and our own led us to propose that the PB2 signature transcriptome might serve to inform strategies for predicting embryo viability (22, 33, 34). Microarray approach is a very useful tool for the discovery of the genomic profiling of zygotes and PBs. We expect that further study will demonstrate intriguing correlations between transcript levels in zygotes and PBs. Such findings would be useful not only to characterize normal development, but also to understand the effects of exposure to abnormal culture environments on preimplantation development.

PB biopsy involves careful removal of a PB through microdissection, which has been proven to be a safe procedure that can be used in mice and humans (35, 36). For successful transition into a clinical application using this approach, we biopsied the PB2 and continuously culture the sibling zygotes in order to evaluate the relationship between maternal-effect gene expression levels in PB2 and the embryonic developmental competence of its sibling zygotes to determine the predictive value of gene expression as biomarkers. We found the transcript levels of Dnmt1, Nobox, Npm2 and Tcl1 in PB2 resulting in blastocysts were significantly up-regulated compared with those resulting in 2-cell stage embryos. Successful preimplantation embryo development depends on the oocyte be sufficiently equipped with stored maternal products. Up to 10% of maternal mRNA persist until the blastocyst stage of development and thus could have a critical roles that extends beyond ensuring embryonic gene activation (EGA) (37). Wells et al revealed that embryos with patterns of gene expression appropriate for their developmental stage have superior viability to those displaying atypical gene activities (38). Our prior work quantified 6 maternal-effect mRNA transcripts in PB1 from young and aged mouse MII oocytes and demonstrated that there is a significant difference in the transcript levels of oocyte-specific genes in aged vs. young PB that correlates with age-related decreases in oocyte competence (17). This study and our previous data led us to propose that a PB biopsy to measure maternal-effect mRNA abundance may serve as biomarkers of embryo competence (39). Future studies are needed to evaluate dynamic changes in mRNA turnover in PB2, as well as to identify a cohort of transcripts that are reliably detected in PB2, whose expression levels are predictive of the developmental competence of a given zygote and its resulting embryo.

Early embryonic development is regulated both genetically and epigenetically. During the development process, the epigenetic signature changes as the cell enters fertilization and/or differentiation. DNA methylation is an important epigenetic event, regulating gene expression and chromatin structure in any developmental processes. To maintain methylated DNA, DNA methyltransferases (DNMTs) are necessary. Dnmt1 enzyme is the main methyltransferase by far. Genetic studies have suggestion Dnmt1 may play a role in the methylation of repeat element in growing oocytes and embryogenesis (4042). Assou et al. found that Dnmt1 were over expressed in mature MII oocytes and decreased progressively in embryos on Day3. In our study, Dnmt1 were highly expressed in PB2, which was significantly up-regulated in PB2 associated with embryo development potential. Indeed, Li et al. demonstrated that targeted mutation of DNA methyltransferase gene results in embryonic lethality. A high level of Dnmt1 is necessary and sufficient to ensure maintain DNA imprints and therefore be a biomarker for optimal embryonic development. The further study of the methylome and the epigenome is important because minor defects can lead to serious human disease (43).

The availability of technical platforms and whole genome microarrays will accelerate our understanding the molecular programme controlling the preimplantation embryo development and identifying specific gene function during preimplantation development. The PB samples indirectly offer the possibilities to gain deep insights into the intricate mechanisms underlying the development of embryo competence. The unraveling of this information will ultimately lead to improved efficiency and health outcomes (i.e. reduced prematurity/perinatal mortality rate and maternal and pediatric complications) of ART. With the availability of a reliable approach capable of identifying the best quality oocytes/embryos, multiple embryo transfer may no longer be necessary in the future.

In conclusion, this is first study to report a differential gene expression between mouse PB2 from zygote resulting in different embryo development potential. This analysis is a novel concept, and demonstrates that it is possible to accurately quantify several genes in a single PB using real-time qPCR, and these genes may serve as new biomarker candidates to assess the embryo quality. Future studies are needed to correlate gene function and regulation to specific events in early embryonic development, which can facilitate the identification of new biomarkers. These tools may ultimately lead to non-invasive tests for oocyte or embryo quality. Once fully validated, these new approaches are expected to improve oocyte and embryo selection, leading to increased implantation rates (44).

Table 2
Transcript levels and detection of mRNA in single polar bodies

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

1. Inge GB, Brinsden PR, Elder KT. Oocyte number per live birth in IVF: were Steptoe and Edwards less wasteful? Hum Reprod. 2005;20:588–92. [PubMed]
2. Kovalevsky G, Patrizio P. High rates of embryo wastage with use of assisted reproductive technology: a look at the trends between 1995 and 2001 in the United States. Fertil Steril. 2005;84:325–30. [PubMed]
3. Li Q, McKenzie LJ, Matzuk MM. Revisiting oocyte-somatic cell interactions: in search of novel intrafollicular predictors and regulators of oocyte developmental competence. Mol Hum Reprod. 2008;14:673–8. [PMC free article] [PubMed]
4. Rienzi L, Ubaldi F, Iacobelli M, Romano S, Minasi MG, Ferrero S, et al. Significance of morphological attributes of the early embryo. Reprod Biomed Online. 2005;10:669–81. [PubMed]
5. Hillier SG. Research challenge: what is the best non-invasive test of oocyte/embryo competence? Mol Hum Reprod. 2008;14:665. [PubMed]
6. Sutovsky P, Schatten G. Paternal contributions to the mammalian zygote: fertilization after sperm-egg fusion. Int Rev Cytol. 2000;195:1–65. [PubMed]
7. Li L, Zheng P, Dean J. Maternal control of early mouse development. Development. 2010;137:859–70. [PubMed]
8. Tong ZB, Gold L, Pfeifer KE, Dorward H, Lee E, Bondy CA, et al. Mater, a maternal effect gene required for early embryonic development in mice. Nat Genet. 2000;26:267–8. [PubMed]
9. Wu X, Viveiros MM, Eppig JJ, Bai Y, Fitzpatrick SL, Matzuk MM. Zygote arrest 1 (Zar1) is a novel maternal-effect gene critical for the oocyte-to-embryo transition. Nat Genet. 2003;33:187–91. [PubMed]
10. Burns KH, Viveiros MM, Ren Y, Wang P, DeMayo FJ, Frail DE, et al. Roles of NPM2 in chromatin and nucleolar organization in oocytes and embryos. Science. 2003;300:633–6. [PubMed]
11. Narducci MG, Fiorenza MT, Kang SM, Bevilacqua A, Di Giacomo M, Remotti D, et al. TCL1 participates in early embryonic development and is overexpressed in human seminomas. Proc Natl Acad Sci U S A. 2002;99:11712–7. [PubMed]
12. Tripurani SK, Lee KB, Wang L, Wee G, Smith GW, Lee YS, et al. A novel functional role for the oocyte-specific transcription factor newborn ovary homeobox (NOBOX) during early embryonic development in cattle. Endocrinology. 2011;152:1013–23. [PubMed]
13. Patrizio P, Fragouli E, Bianchi V, Borini A, Wells D. Molecular methods for selection of the ideal oocyte. Reprod Biomed Online. 2007;15:346–53. [PubMed]
14. Kuliev A, Rechitsky S. Polar body based preimplantation genetic diagnosis for Mendelian disorders. Mol Hum Reprod. 2011;17:275–85. [PubMed]
15. Klatsky PC, Wessel GM, Carson SA. Detection and quantification of mRNA in single human polar bodies: a minimally invasive test of gene expression during oogenesis. Mol Hum Reprod. 2010;16:938–43. [PubMed]
16. Reich A, Klatsky P, Carson S, Wessel G. The transcriptome of a human polar body accurately reflects its sibling oocyte. J Biol Chem. 2011;286:40743–9. [PubMed]
17. Jiao ZX, Xu M, Woodruff TK. Age-associated alteration of oocyte-specific gene expression in polar bodies: potential markers of oocyte competence. Fertil Steril. 2012;98:480–6. [PMC free article] [PubMed]
18. Montag M, van der Ven K, Delacretaz G, Rink K, van der Ven H. Laser-assisted microdissection of the zona pellucida facilitates polar body biopsy. Fertil Steril. 1998;69:539–42. [PubMed]
19. Aoki F, Worrad DM, Schultz RM. Regulation of transcriptional activity during the first and second cell cycles in the preimplantation mouse embryo. Dev Biol. 1997;181:296–307. [PubMed]
20. Gardner RL. The early blastocyst is bilaterally symmetrical and its axis of symmetry is aligned with the animal-vegetal axis of the zygote in the mouse. Development. 1997;124:289–301. [PubMed]
21. Fabian D, Cikos S, Rehak P, Koppel J. Do embryonic polar bodies commit suicide? Zygote. 2012:1–8. [PubMed]
22. VerMilyea MD, Maneck M, Yoshida N, Blochberger I, Suzuki E, Suzuki T, et al. Transcriptome asymmetry within mouse zygotes but not between early embryonic sister blastomeres. EMBO J. 2011;30:1841–51. [PubMed]
23. Zuccotti M, Boiani M, Ponce R, Guizzardi S, Scandroglio R, Garagna S, et al. Mouse Xist expression begins at zygotic genome activation and is timed by a zygotic clock. Mol Reprod Dev. 2002;61:14–20. [PubMed]
24. Steuerwald N, Cohen J, Herrera RJ, Brenner CA. Quantification of mRNA in single oocytes and embryos by real-time rapid cycle fluorescence monitored RT-PCR. Mol Hum Reprod. 2000;6:448–53. [PubMed]
25. Wang QT, Piotrowska K, Ciemerych MA, Milenkovic L, Scott MP, Davis RW, et al. A genome-wide study of gene activity reveals developmental signaling pathways in the preimplantation mouse embryo. Dev Cell. 2004;6:133–44. [PubMed]
26. Bachvarova R. Gene expression during oogenesis and oocyte development in mammals. Dev Biol (N Y 1985) 1985;1:453–524. [PubMed]
27. Paynton BV, Rempel R, Bachvarova R. Changes in state of adenylation and time course of degradation of maternal mRNAs during oocyte maturation and early embryonic development in the mouse. Dev Biol. 1988;129:304–14. [PubMed]
28. Alizadeh Z, Kageyama S, Aoki F. Degradation of maternal mRNA in mouse embryos: selective degradation of specific mRNAs after fertilization. Mol Reprod Dev. 2005;72:281–90. [PubMed]
29. Su YQ, Sugiura K, Woo Y, Wigglesworth K, Kamdar S, Affourtit J, et al. Selective degradation of transcripts during meiotic maturation of mouse oocytes. Dev Biol. 2007;302:104–17. [PMC free article] [PubMed]
30. Schultz RM. Regulation of zygotic gene activation in the mouse. Bioessays. 1993;15:531–8. [PubMed]
31. Hamatani T, Carter MG, Sharov AA, Ko MS. Dynamics of global gene expression changes during mouse preimplantation development. Dev Cell. 2004;6:117–31. [PubMed]
32. Macara IG, Mili S. Polarity and differential inheritance--universal attributes of life? Cell. 2008;135:801–12. [PMC free article] [PubMed]
33. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010;7:618–30. [PMC free article] [PubMed]
34. Brison DR, Hollywood K, Arnesen R, Goodacre R. Predicting human embryo viability: the road to non-invasive analysis of the secretome using metabolic footprinting. Reprod Biomed Online. 2007;15:296–302. [PubMed]
35. Cieslak-Janzen J, Tur-Kaspa I, Ilkevitch Y, Bernal A, Morris R, Verlinsky Y. Multiple micromanipulations for preimplantation genetic diagnosis do not affect embryo development to the blastocyst stage. Fertil Steril. 2006;85:1826–9. [PubMed]
36. Kaplan B, Wolf G, Kovalinskaya L, Verlinsky Y. Viability of embryos following second polar body removal in a mouse model. J Assist Reprod Genet. 1995;12:747–9. [PubMed]
37. Bell CE, Calder MD, Watson AJ. Genomic RNA profiling and the programme controlling preimplantation mammalian development. Mol Hum Reprod. 2008;12:691–701. [PMC free article] [PubMed]
38. Wells D, Bermudez MG, Steuerwald N, Thornhill AR, Walker DL, Malter H, et al. Expression of genes regulating chromosome segregation, the cell cycle and apoptosis during human preimplantation development. Hum Reprod. 2005;20:1339–48. [PubMed]
39. Jiao ZX, Woodruff TK. Follicle microenvironment-associated alterations in gene expression in the mouse oocyte and its polar body. Fertil Steril. Jan 8; [PubMed]
40. Howell CY, Bestor TH, Ding F, Latham KE, Mertineit C, Trasler JM, et al. Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 gene. Cell. 2001;104:829–38. [PubMed]
41. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 1992;69:915–26. [PubMed]
42. Gaudet F, Rideout WM, 3rd, Meissner A, Dausman J, Leonhardt H, Jaenisch R. Dnmt1 expression in pre- and postimplantation embryogenesis and the maintenance of IAP silencing. Mol Cell Biol. 2004;24:1640–8. [PMC free article] [PubMed]
43. Amor DJ, Halliday J. A review of known imprinting syndromes and their association with assisted reproduction technologies. Hum Reprod. 2008;23:2826–34. [PubMed]
44. Assou S, Boumela I, Haouzi D, Anahory T, Dechaud H, De Vos J, et al. Dynamic changes in gene expression during human early embryo development: from fundamental aspects to clinical applications. Hum Reprod Update. 2011;17:272–90. [PMC free article] [PubMed]